Blood Management for Pediatric Cardiac Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on improving blood management for children undergoing heart surgery. Researchers aim to determine the optimal type and amount of blood products for use during these procedures. They also intend to develop a model to predict and assist in treating children who require blood transfusions. The trial seeks participants under 18 undergoing heart surgery with a heart-lung machine at Boston Children's Hospital. As an unphased trial, it offers a unique opportunity for participants to contribute to pioneering research that could significantly enhance surgical outcomes for children.
Do I need to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but it mentions that patients on certain blood thinners like heparin, apixaban, warfarin, or bivalirudin can participate if these are held appropriately for elective surgery. It's best to discuss your specific medications with the trial team.
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to improve blood management and reduce hemolytic risk in pediatric heart surgery, a crucial area that often relies on standard blood transfusion protocols. Unlike traditional methods, this trial at Boston Children's Hospital focuses on children undergoing heart surgery with cardio-pulmonary bypass, exploring ways to better model and manage blood use during these procedures. By potentially refining how blood is managed during surgery, this approach could lessen the risk of complications related to blood cell destruction, offering a safer surgical experience for young patients.
Who Is on the Research Team?
Koichi Yuki, MD
Principal Investigator
Boston Children's Hospital
Are You a Good Fit for This Trial?
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Blood management strategies are applied during heart surgery, including administration of blood products and monitoring of hemolytic risk
Follow-up
Participants are monitored for safety and effectiveness of blood management strategies after surgery
What Are the Treatments Tested in This Trial?
Interventions
- Blood Sampling
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Children under 18 years of age having heart surgery with cardio-pulmonary bypass at Boston Children's Hospital
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston Children's Hospital
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.